Casdin Capital, LLC
CIK 1534261 · Holdings on Jun 30, 2024 · First reported Oct 18, 2024
Top ten holdings
Q2 2024- BLFS14.25%
- RVMD13.06%
- SRPT12.95%
- LAB8.64%
- WGS7.04%
- RNA6.50%
- RLAY4.21%
- ILMN3.83%
- NTLA3.42%
- ALNY3.15%
Share classes counted separately77.05%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- WGSWeight increased · +4.91 pp2.13% → 7.04%Shares +390.00K (+12.43%)
- LABWeight decreased · -3.84 pp12.48% → 8.64%Shares +2.05M (+3.31%)
- SRPTWeight increased · +2.65 pp10.30% → 12.95%Shares +4.50K (+0.42%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 30
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | BLFSBIOLIFE SOLUTIONS INCCOM NEW View history and evidence | $186.59M | 14.25% | 8.71M shares | 12.02% → 14.25%+2.23 pp 0 (0.00%) | Unchanged | ↗▾ |
| 02 | RVMDREVOLUTION MEDICINES INC View history and evidence | $171.03M | 13.06% | 4.41M shares | 13.47% → 13.06%-0.41 pp -1.21M (-21.55%) | Reduced | ↗▾ |
| 03 | SRPTSAREPTA THERAPEUTICS INC View history and evidence | $169.61M | 12.95% | 1.07M shares | 10.30% → 12.95%+2.65 pp +4.50K (+0.42%) | Added | ↗▾ |
| 04 | LABSTANDARD BIOTOOLS INC View history and evidence | $113.21M | 8.64% | 63.96M shares | 12.48% → 8.64%-3.84 pp +2.05M (+3.31%) | Added | ↗▾ |
| 05 | WGSGENEDX HOLDINGS CORPCOM CL A View history and evidence | $92.18M | 7.04% | 3.53M shares | 2.13% → 7.04%+4.91 pp +390.00K (+12.43%) | Added | ↗▾ |
| 06 | RNAAVIDITY BIOSCIENCES INC View history and evidence | $85.17M | 6.50% | 2.08M shares | 3.96% → 6.50%+2.54 pp 0 (0.00%) | Unchanged | ↗▾ |
| 07 | RLAYRELAY THERAPEUTICS INC View history and evidence | $55.08M | 4.21% | 8.45M shares | 4.59% → 4.21%-0.38 pp +1.02M (+13.81%) | Added | ↗▾ |
| 08 | ILMNILLUMINA INC View history and evidence | $50.10M | 3.83% | 480.00K shares | 2.53% → 3.83%+1.30 pp +232.00K (+93.55%) | Added | ↗▾ |
| 09 | NTLAINTELLIA THERAPEUTICS INC View history and evidence | $44.76M | 3.42% | 2.00M shares | 3.84% → 3.42%-0.42 pp +125.00K (+6.67%) | Added | ↗▾ |
| 10 | ALNYALNYLAM PHARMACEUTICALS INC View history and evidence | $41.31M | 3.15% | 170.00K shares | 3.98% → 3.15%-0.83 pp -188.00K (-52.51%) | Reduced | ↗▾ |
Options overlay 0
No options reported this quarter.
Exited positions 2
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| ABCL ABCELLERA BIOLOGICS INC | Non-derivative | -2,360,129 | -$10.69M | SEC filing ↗ | SEC filing ↗ |
| NTLA INTELLIA THERAPEUTICS INC | Call | -50,000 | -$1.38M | SEC filing ↗ | SEC filing ↗ |
2 / 2 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1534261 · Period 2024-06-30
Data loaded 2026-09-23 · First reported 2024-10-18
Amendments and versions
{
"amendments_merged": [
{
"action": "REPLACE",
"accession": "0000919574-24-005948",
"cover_total": 1309655420,
"filing_date": "2024-10-18",
"claimed_type": "RESTATEMENT",
"confidential": false,
"positions_added": 0,
"positions_restated": 1,
"positions_cancelled": 0
}
],
"prior_versions": [
{
"accession": "0000919574-24-004750",
"filing_date": "2024-08-14",
"confidential": false,
"cover_table_value_total_raw": 1304595899
}
],
"cover_table_value": 1309655420
}Research all 38 reported holdings.
This page includes 30 of 38 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 30 of 38 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1534261","quarter":"2024Q2","page_size":100}
get_institutional_manager_history
{"cik":"1534261","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.